Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    20160249 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  TB-IRIS NSAID Cox-2 Inhibitor Prevention Trial
Condition: Tuberculosis
Intervention: Drug: Meloxicam 7.5mg daily for 8 weeks

Study has passed its completion date and status has not been verified in more than two years.